Literature DB >> 11867013

The nine ages of herpes simplex virus.

B Roizman1, R J Whitley.   

Abstract

Hippocrates was the first to describe lesions that could have been caused by herpes simplex virus (HSV), but the clinical conditions caused by this virus have only been described in more detail over the past 3 centuries. Most of the key findings relating to HSV infection and treatment have been made since the early 20th Century. These range from discovering some of the mechanisms behind virus latency and reactivation, to the development of the drug aciclovir, which was the first selective inhibitor of HSV replication. This review provides an evolutionary understanding of HSV, but HSV research is still in its golden age. New facts continue to emerge about HSV, and manipulation of the virus is providing much information. Genetic engineering of this virus is likely to have a most significant impact on future medical therapies, which could extend to specialties beyond virology.

Entities:  

Mesh:

Year:  2001        PMID: 11867013

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  14 in total

Review 1.  The checkpoints of viral gene expression in productive and latent infection: the role of the HDAC/CoREST/LSD1/REST repressor complex.

Authors:  Bernard Roizman
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

2.  Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1.

Authors:  Daniel S Mansur; Erna G Kroon; Maurício L Nogueira; Rosa M E Arantes; Soraia C O Rodrigues; Shizuo Akira; Ricardo T Gazzinelli; Marco A Campos
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

Review 3.  Investigating the biology of alpha herpesviruses with MS-based proteomics.

Authors:  Esteban A Engel; Ren Song; Orkide O Koyuncu; Lynn W Enquist
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

Review 4.  Laboratory Diagnosis of Neonatal Herpes Simplex Virus Infections.

Authors:  William J Muller; Xiaotian Zheng
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

5.  HSV-1 miR-H6 inhibits HSV-1 replication and IL-6 expression in human corneal epithelial cells in vitro.

Authors:  Fang Duan; Jingyu Liao; Qiang Huang; Yuhong Nie; Kaili Wu
Journal:  Clin Dev Immunol       Date:  2012-04-09

Review 6.  Applications of gold nanoparticles in virus detection.

Authors:  Mohamed Shehata Draz; Hadi Shafiee
Journal:  Theranostics       Date:  2018-02-15       Impact factor: 11.556

7.  Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population.

Authors:  Lisa N Akhtar; Christopher D Bowen; Daniel W Renner; Utsav Pandey; Ashley N Della Fera; David W Kimberlin; Mark N Prichard; Richard J Whitley; Matthew D Weitzman; Moriah L Szpara
Journal:  mSphere       Date:  2019-02-27       Impact factor: 4.389

Review 8.  Evasion of early antiviral responses by herpes simplex viruses.

Authors:  Paula A Suazo; Francisco J Ibañez; Angello R Retamal-Díaz; Marysol V Paz-Fiblas; Susan M Bueno; Alexis M Kalergis; Pablo A González
Journal:  Mediators Inflamm       Date:  2015-03-30       Impact factor: 4.711

9.  Implementation and Evaluation of a Fully Automated Multiplex Real-Time PCR Assay on the BD Max Platform to Detect and Differentiate Herpesviridae from Cerebrospinal Fluids.

Authors:  Thomas Köller; Daniel Kurze; Mirjam Lange; Martin Scherdin; Andreas Podbielski; Philipp Warnke
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

Review 10.  Clinical management of herpes simplex virus infections: past, present, and future.

Authors:  Richard Whitley; Joel Baines
Journal:  F1000Res       Date:  2018-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.